SiVEC Biotechnologies is developing a breakthrough delivery platform for nucleic acid drugs and gene-editing tools using non-pathogenic, non-immunogenic bacteria for stable and specific delivery to mucosal tissues without host genomic integration.
SiVEC Biotechnologies is developing a breakthrough delivery platform for nucleic acid drugs and gene-editing tools using non-pathogenic, non-immunogenic bacteria for stable and specific delivery to mucosal tissues without host genomic integration.